No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

VirtaMed Announces New Inclusive Knee Simulation Model

Editor: What To Know

  • The new training options are the most recent in a series of updates stemming from a collaborative agreement between VirtaMed and the AANA to advance and improve arthroscopy surgery skill training and develop standards for proficiency-based training curricula.
  •  Since 2018, AANA experts have collaborated with VirtaMed to provide expert input on cases and courses for training on the fundamentals of arthroscopy (FAST), and the knee, shoulder and hip joints.
  • The VirtaMed ArthroS™ is unique in simulation training as trainees are able to palpate and distract a physical model while at the same time performing a virtual surgery.

VirtaMed, the world leader in medical simulation training, has announced the release of enhanced simulation training modules for arthroscopic knee surgeries. In a first for VirtaMed, these latest training modules will now be available on simulators with two different skin tones.

“It is important to learn medical skills in a realistic environment, and that means training on simulators that reflect the diversity of both patients and trainee physicians,” said Dr. Raimundo Sierra, founder and CEO of VirtaMed. “VirtaMed is committed to encouraging diversity and inclusion in the education of medical skills, and we believe these values should also be reflected in the simulator hardware. This is just one step in the right direction toward more equitable healthcare education and delivery.”

2005 report released by the Institute of Medicine documented that “racial and ethnic minorities receive lower-quality health care than white people — even when insurance status, income, age and severity of conditions are comparable.” While not referring specifically to surgical outcomes, the report and similar studies have indicated that people of color are less likely to receive effective treatments, due in part to implicit bias from healthcare providers.

In developing the new simulators, VirtaMed collaborated with knee experts Dr. Jacqueline Brady, Dr. Cassandra Lee, and Dr. Patrick Joyner from the AANA Knee Taskforce. VirtaMed and AANA knee experts identified high-priority new cases and features with the most potential impact for training the next generation of surgeons. The VirtaMed ArthroS™ is unique in simulation training as trainees are able to palpate and distract a physical model while at the same time performing a virtual surgery.

The new training options are the most recent in a series of updates stemming from a collaborative agreement between VirtaMed and the AANA to advance and improve arthroscopy surgery skill training and develop standards for proficiency-based training curricula. Since 2018, AANA experts have collaborated with VirtaMed to provide expert input on cases and courses for training on the fundamentals of arthroscopy (FAST), and the knee, shoulder and hip joints.

The new model, as well as additional software upgrades, will be unveiled at this year’s American Academy of Orthopaedic Surgeons (AAOS) conference held in Chicago, March 22-26. 2022. Live demonstrations will be held at booth 1421 and can be reserved at virtamed.com.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy